- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06153381
Virtual Rehabilitation Assistant Via Instant Messaging Communication to Promote Adherence to Rehabilitation After Reverse Shoulder Replacement (SIP_LaFe)
December 4, 2023 updated by: Jose María Blasco Igual, University of Valencia
Herramienta de Procesamiento de Lenguaje Natural en Dispositivo móvil Inteligente Para Asegurar la Adherencia a la rehabilitación Domiciliaria en cirugías de Artroplastia Invertida de Hombro (NLP-PTAdherence)
reverse shoulder replacement surgery is performed to improve the functionality and reduce pain of the affected shoulder.
Now, it is necessary to carry out an appropriate rehabilitation process to optimize surgical results.
The lack of health resources makes it essential for the patient to work autonomously once hospital rehabilitation is completed.
But lack of adherence is one of the main barriers to recovery
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective is to evaluate the effectiveness of a Chatbot that interacts with patients via instant messaging to supervise home rehabilitation and increase adherence.
Conduct a feasibility study with a pilot sample
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Valencia
-
València, Valencia, Spain, 46026
- Recruiting
- Hospital Universitario y Politécnico La Fe
-
Contact:
- Marta Navarro, MD
- Phone Number: 961 24 40 00
- Email: mnb18504@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients undergoing reverse shoulder replacement
- With a personal smartphone
- An instant messaging application installed
- Familiar with the use of such an application (i.e., at least three accessess per week)
- Able to write and read in the Spanish language
Exclusion Criteria:
- Condition, whether cognitive, neurological, integrative or musculoskeletal, that obviously prevents understanding or performing the exercises of the rehabilitation program or may pose a risk to the patient's health.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard care
|
Rehabilitation program based on standard care, assisted with one education session plus informative brochure
|
Experimental: Chatbot care
|
Rehabilitation program based on standard care, but assisted via an instant messaging application using a personal smartphone
Rehabilitation program based on standard care, assisted with one education session plus informative brochure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shoulder disability
Time Frame: 0 weeks, 12 weeks
|
This is measured with the Quick Dash questionnaire, a self-reported survey of 11 items designed to assess symptoms and ability to perform certain activities.
At least 10 items should be answered to calculate a score.
Each answer can be scored from one to five, and the average value is calculated, thus obtaining a score from one to five.
Then, to express the score in percentages, 1 is subtracted from the result and then multiplied by 25.
The higher the score, the greater the disability.
|
0 weeks, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shoulder functionality
Time Frame: 0 weeks, 12 weeks
|
measured with the Constant-Murley Score, a multi-item functional scale assessing pain, ADL, ROM and strength of the affected shoulder.
Its score ranges from 0 to 100 points, representing worst and best shoulder function, respectively
|
0 weeks, 12 weeks
|
Shoulder pain
Time Frame: 0 weeks, 12 weeks
|
Assessed with a numeric pain rating scale, ranging from 0, the worst possible pain, to 10, no pain, with the question: What was your overall pain in the shoulder in the last week?
|
0 weeks, 12 weeks
|
Quality of Life
Time Frame: 0 weeks, 12 weeks
|
measured with the EQ-5D-5L quetionnaire, which essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.
|
0 weeks, 12 weeks
|
Number of sessions of rehabilitation completed
Time Frame: 12 weeks
|
Compliance with rehabilitation, measuring the number of sessions completed
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2023
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
November 22, 2023
First Submitted That Met QC Criteria
November 22, 2023
First Posted (Actual)
December 1, 2023
Study Record Updates
Last Update Posted (Actual)
December 12, 2023
Last Update Submitted That Met QC Criteria
December 4, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIP_LaFe
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Osteoarthritis
-
Indiana Hand to Shoulder CenterCTM BiomedicalActive, not recruitingShoulder Osteoarthritis | Osteoarthritis Shoulder | Glenohumeral OsteoarthritisUnited States
-
Smith & Nephew, Inc.Recruiting
-
Lovisenberg Diakonale HospitalHaukeland University Hospital; Sykehuset Telemark; University Hospital, AkershusRecruitingShoulder Osteoarthritis | Arthroplasty, Replacement, ShoulderNorway
-
University Hospital, BrestUnknownShoulder Osteoarthritis | Arthropathy ShoulderFrance
-
FX Shoulder SolutionsRecruitingOsteoarthritis Shoulder | Rotator Cuff Syndrome of Shoulder and Allied Disorders | Fracture, ShoulderUnited States
-
Northwestern UniversityWithdrawnShoulder Osteoarthritis | Arthropathy ShoulderUnited States
-
FX Shoulder SolutionsRecruitingOsteoarthritis Shoulder | Rotator Cuff Syndrome of Shoulder and Allied Disorders | Fracture, ShoulderUnited States
-
Zealand University HospitalHvidovre University HospitalActive, not recruitingShoulder Pain | Shoulder Osteoarthritis | Shoulder ArthritisDenmark
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Lawson Health Research InstituteRecruitingPain Management | Shoulder Arthroplasty | Shoulder OsteoarthritisCanada
Clinical Trials on Chatbot
-
University of Maryland, College ParkCompletedCervical Cancer | Anal Cancer | Penile CancerUnited States
-
Yonsei UniversityCompletedBreast NeoplasmsKorea, Republic of
-
Weill Medical College of Cornell UniversityRecruitingGynecologic Cancer | Hereditary Cancer SyndromeUnited States
-
Sun Yat-sen UniversityRecruiting
-
Cheng-Hsin General HospitalRecruitingLower Urinary Tract Symptoms | Erectile Dysfunction | Benign Prostate EnlargementTaiwan
-
Abramson Cancer Center at Penn MedicineRecruitingHead and Neck Cancer | Lung Cancer | Gastrointestinal CancerUnited States
-
University of Social Sciences and Humanities, WarsawMinistry of Science and Higher Education, PolandCompletedDepression | AnxietyPoland
-
Adonis Hijaz, MDRecruiting
-
University Hospital, ToulouseNot yet recruiting
-
University of ChicagoNorthShore University HealthSystemCompletedDepression, Postpartum | Depression, UnipolarUnited States